Low-Dose Berberine Attenuates the Anti-Breast Cancer Activity of Chemotherapeutic Agents via Induction of Autophagy and Antioxidation

Berberine (BBR), a major active component of Rhizoma coptidis, is one of the most promising agents for breast cancer adjuvant therapy. It is well accepted that BBR could exhibit remarkable anticancer efficacy with few side effects, and when treated with chemotherapeutic agents in combination, BBR co...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Bing, Wang, Kai, Tu, Yanbei, Tan, Lihua, He, Chengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549173/
https://www.ncbi.nlm.nih.gov/pubmed/33100936
http://dx.doi.org/10.1177/1559325820939751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549173/
https://www.ncbi.nlm.nih.gov/pubmed/33100936
http://dx.doi.org/10.1177/1559325820939751

Ejemplares similares